If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Portfolio Pulse from Benzinga Insights
CRISPR Therapeutics (NASDAQ:CRSP) has delivered an average annual return of 14.35% over the past 5 years, outperforming the market by 1.56% annually. A $100 investment in CRSP 5 years ago would be worth $200.99 today. The company's market cap stands at $4.96 billion.
January 22, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CRISPR Therapeutics has shown strong performance with a 14.35% average annual return over the past 5 years, doubling a $100 investment.
The positive historical performance data for CRISPR Therapeutics suggests investor confidence and could attract more interest in the stock. However, past performance is not always indicative of future results, and investors should consider current market conditions and future prospects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100